Suppression of F(ENO) with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?

F(ENO) suppression testing is practical and feasible during assessment for biologics in severe asthma. Patients with significant F(ENO) suppression were less likely to be recommended biologics but saw similar reductions in exacerbation frequency. http://bit.ly/35oSoxP

Detalles Bibliográficos
Autores principales: Faruqi, Shoaib, Zhou, Sean, Thompson, Joanne, Robinson, Terry, Watkins, Karen, Cummings, Helena, Jackson, Nicola, Prakash, Anoop, Crooks, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876132/
https://www.ncbi.nlm.nih.gov/pubmed/31777751
http://dx.doi.org/10.1183/23120541.00123-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876132/
https://www.ncbi.nlm.nih.gov/pubmed/31777751
http://dx.doi.org/10.1183/23120541.00123-2019

Ejemplares similares